Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00094614 · ClinicalTrials.gov registry record · Phase 4
Trial Comparing Daily Atropine Versus Weekend Atropine
A Phase 4 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 168
- Enrollment target
NCT00094614 is a Phase 4 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 168 participants.
The verdict
NCT00094614, a Phase 4 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 168 participants
- Enrollment target
Study Summary
The goals of this study are: * To compare the visual acuity outcome in the amblyopic eye after 17 weeks of daily use of atropine versus weekend-only use of atropine. * To compare the proportion of patients achieving a complete treatment response (defined as amblyopic eye acuity \>20/25 or equal to that of the sound eye in the absence of a reduction in the sound eye acuity from baseline) with daily atropine versus weekend-only atropine.
Interventions
- DRUG Atropine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2002-06 |
| Est. Completion | 2003-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00094614
The ClinicalTrials.gov registry entry for NCT00094614 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Atropine is the first listed.
NCT00094614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00094614 about?
NCT00094614 is a clinical study titled "Trial Comparing Daily Atropine Versus Weekend Atropine". The goals of this study are: * To compare the visual acuity outcome in the amblyopic eye after 17 weeks of daily use of atropine versus weekend-only use of atropine. * To compare the proportion of patients achieving a complete treatment response (defined as amblyopic eye acuity \>20/25 or equal to ...
What is the current status of trial NCT00094614?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 168 participants. The study started on 2002-06. Estimated completion is 2003-04.
What interventions are being tested in trial NCT00094614?
The interventions under investigation include: Atropine (DRUG).
Who is sponsoring clinical trial NCT00094614?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.